1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow BRCA2 Mutation Carrier: new trials by email Literature Review of BRCA2 Mutation Carrier trials Research Report on BRCA2 Mutation Carrier
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors veliparib, capecitabine, oxaliplatin - Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach | Phase 1 | Terminated | National Cancer Institute (NCI) | 16 | 2010-10-01 | 2014-04-02 |
Breast Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Stomach Neoplasms (1)
Adnexal Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1)
Capecitabine (1) · Oxaliplatin (1) · veliparib (1)
National Cancer Institute (NCI) (1)
United States (1)
William Schelman (1)
P30CA014520 (1), U01CA062491 (1)